Discovery of Simian Virus 40 (SV40) and its relationship to poliomyelitis virus vaccines

被引:0
|
作者
Hilleman, MR [1 ]
机构
[1] Merck Inst Therapeut Res, Merck Res Labs, W Point, PA 19486 USA
关键词
Simian Virus 40; SV40; poliomyelitis; polyomavirus;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simian Virus 40 (SV40) was discovered in 1959 as a covert contaminant of poliovirus vaccines prepared using Macacus monkey renal cell cultures. This inapparent polyoma virus of monkeys was detected using Cercopithecus renal cell cultures and was eliminated from poliovaccines. Them has been no evidence to implicate SV40 virus of vaccine origin in long- or short-term consequences in human subjects. Of importance, SV40 virus provided a new model for basic studies of viral pathogenesis and for cell transformation and neoplasia. Neoplastic transformation is fixed on the promiscuous binding of SV40 large T antigen to anti-oncogene cellular protein elements. SV40 also served as a valuable model for defining the immunology of virus-induced cancer and in its prevention and cure. Further, it has been a prime tool for elucidating the molecular details of eukaryotic cell processes. Numerous techniques now used in molecular biology were pioneered in the SV40 system. The SV40 promoter is commonly used in vector expression constructs and it has continued to be a model to develop new tools for site-specific mutagenesis. The virus has been critically important to studies in modern genetics and in molecular biology.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 50 条
  • [31] Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects
    Paracchini, V
    Garte, S
    Pedotti, P
    Taioli, E
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2006, 612 (02) : 77 - 83
  • [32] SUSCEPTIBILITY OF TRISOMIC AND OF TRIPLOID HUMAN FIBROBLASTS TO SIMIAN VIRUS-40 (SV40)
    PAYNE, FE
    SCHMICKEL, RD
    NATURE-NEW BIOLOGY, 1971, 230 (14): : 190 - +
  • [33] Association of Simian Virus 40 (SV40) with human breast carcinomas in Tunisian women
    Hachana, M.
    Trimeche, M.
    Ziadi, S.
    Amara, K.
    Gacem, R.
    Zaghdoudi, R.
    Mokni, M.
    Korbi, S.
    EJC SUPPLEMENTS, 2008, 6 (09): : 51 - 51
  • [34] Immunohistochemical detection of Simian Virus 40 (SV40) in 30 mesothelioma and 97 sarcoma
    da Cunha, Isabela Werneck
    Vassallo, Jose
    Schenka, Andre Almeida
    Soares, Fernando Augusto
    VIRCHOWS ARCHIV, 2008, 452 : S54 - S54
  • [35] CONSTRAINTS IN SIMIAN VIRUS-40 (SV40) ENCAPSIDATION, AS DETERMINED BY SV40-BASED SHUTTLE VIRUSES
    MENCK, CFM
    JAMES, M
    BENOIT, A
    SARASIN, A
    JOURNAL OF GENERAL VIROLOGY, 1990, 71 : 143 - 150
  • [36] SELECTIVE TRANSFORMATION OF PARTICULAR CELL-TYPES BY SIMIAN VIRUS 40 (SV40)
    RAFFERTY, KA
    ANATOMICAL RECORD, 1975, 181 (02): : 455 - 455
  • [37] ATP STIMULATES THE BINDING OF SIMIAN VIRUS-40 (SV40) LARGE TUMOR-ANTIGEN TO THE SV40 ORIGIN OF REPLICATION
    BOROWIEC, JA
    HURWITZ, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (01) : 64 - 68
  • [38] INVOLVEMENT OF SIMIAN VIRUS-40 (SV40) SMALL T-ANTIGEN IN TRANSACTIVATION OF SV40 EARLY AND LATE PROMOTERS
    BIKEL, I
    LOEKEN, MR
    JOURNAL OF VIROLOGY, 1992, 66 (03) : 1489 - 1494
  • [39] SIMIAN VIRUS-40 (SV40)-TRANSGENIC MICE THAT DEVELOP TUMORS ARE SPECIFICALLY TOLERANT TO SV40 T-ANTIGEN
    FAAS, SJ
    PAN, S
    PINKERT, CA
    BRINSTER, RL
    KNOWLES, BB
    JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02): : 417 - 427
  • [40] ONCOGENICITY OF SIMIAN VIRUS (SV40] AND ITS INACTIVATION WITH BETA-PROPIOLACTONE (BPL]
    HAYASHI, H
    LOGRIPPO, GA
    FEDERATION PROCEEDINGS, 1963, 22 (02) : 438 - &